Dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid: A comparative study of 100 patients with bullous pemphigoid and diabetes mellitus-Reference-Cited by-同舟云学术

Dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid: A comparative study of 100 patients with bullous pemphigoid and diabetes mellitus

Published:2021-02-04 Issue:4 Volume:48 Page:486-496
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J. Dermatol.

Author:

Chanprapaph Kumutnart¹^ORCID,Pratumchart Nathathai¹,Limtong Preeyachat¹,Rutnin Suthinee¹^ORCID,Sukasem Chonlaphat²,Kungvalpivat Pintusorn¹,Triamchaisri Siripich³,Suchonwanit Poonkiat¹^ORCID

Affiliation:

1. Division of Dermatology Faculty of Medicine Ramathibodi HospitalMahidol University Bangkok Thailand

2. Division of Pharmacogenomics and Personalized Medicine Department of Pathology Faculty of Medicine Ramathibodi HospitalMahidol University Bangkok Thailand

3. Department of Medicine Somdech Phra Deparatana Medical Center Faculty of Medicine Ramathibodi HospitalMahidol University Bangkok Thailand

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15778

Reference39 articles.

1. Mortality of bullous pemphigoid in Asia: the same as in Europe?

2. Assessment of the Prevalence of Mucosal Involvement in Bullous Pemphigoid

3. Drug-induced pemphigoid: a review of the literature

4. The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations

5. Increased frequency of diabetes mellitus in patients with bullous pemphigoid: A case-control study

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid diagnosed by oral manifestation;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2023-11

2. The effect of dipeptidyl peptidase‐4 inhibitor on incidence and clinical course in bullous pemphigoid patients in a tertiary medical center;The Kaohsiung Journal of Medical Sciences;2023-08-02

3. Intravenous immunoglobulin in patients with bullous pemphigoid insufficient response to corticosteroids: Nationwide post-marketing surveillance in Japan;Journal of Dermatological Science;2023-01

4. What's new in the pathogeneses and triggering factors of bullous pemphigoid;The Journal of Dermatology;2022-11-22

5. Dipeptidyl-Peptidase 4 Inhibitor-Induced Variants of Bullous Pemphigoid: A Case Series of Four Patients;Case Reports in Dermatology;2022-11-22